Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine with metabolic derangement

[1]  B. Teng,et al.  Impaired Aortic Contractility to Uridine Adenosine Tetraphosphate in Angiotensin II-Induced Hypertensive Mice: Receptor Desensitization? , 2016, American journal of hypertension.

[2]  S. Tilley,et al.  Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: Role of thromboxane and purinergic receptors. , 2015, Vascular pharmacology.

[3]  D. Marks,et al.  Propensity of red blood cells to undergo P2X7 receptor–mediated phosphatidylserine exposure does not alter during in vivo or ex vivo aging , 2015, Transfusion.

[4]  R. Tostes,et al.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes , 2015, British journal of pharmacology.

[5]  K. Taguchi,et al.  Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase/thromboxane receptor axis , 2014, Pflügers Archiv - European Journal of Physiology.

[6]  J. Jankowski,et al.  Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation. , 2013, Pharmacological research.

[7]  W. Paulus,et al.  A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.

[8]  Xi-Long Zheng,et al.  Uridine adenosine tetraphosphate induces contraction of circular and longitudinal gastric smooth muscle by distinct signaling pathways , 2013, IUBMB life.

[9]  G. Burnstock,et al.  Purinergic signalling and diabetes , 2013, Purinergic Signalling.

[10]  D. Duncker,et al.  Nitroso-redox balance in control of coronary vasomotor tone. , 2012, Journal of applied physiology.

[11]  D. Duncker,et al.  Cytochrome P-450 2C9 exerts a vasoconstrictor influence on coronary resistance vessels in swine at rest and during exercise. , 2012, American journal of physiology. Heart and circulatory physiology.

[12]  D. Gutterman,et al.  Regulation of the human coronary microcirculation. , 2012, Journal of molecular and cellular cardiology.

[13]  K. Kamata,et al.  Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism. , 2011, American journal of physiology. Heart and circulatory physiology.

[14]  R. Webb,et al.  The Role of Uridine Adenosine Tetraphosphate in the Vascular System , 2011, Advances in Pharmacological Sciences.

[15]  R. Webb,et al.  Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats. , 2011, American journal of physiology. Heart and circulatory physiology.

[16]  A. Rossi,et al.  Selection of reference genes for normalization of real-time PCR data in minipig heart failure model and evaluation of TNF-α mRNA expression. , 2011, Journal of biotechnology.

[17]  P. Bie,et al.  Uridine adenosine tetraphosphate affects contractility of mouse aorta and decreases blood pressure in conscious rats and mice , 2010, Acta physiologica.

[18]  G. Burnstock.  Control of vascular tone by purines and pyrimidines , 2010, British journal of pharmacology.

[19]  J. Jankowski,et al.  Differential effects of uridine adenosine tetraphosphateon purinoceptors in the rat isolated perfused kidney , 2010, British journal of pharmacology.

[20]  Y. Hellsten,et al.  Attenuated Purinergic Receptor Function in Patients With Type 2 Diabetes , 2009, Diabetes.

[21]  D. Donnelly-roberts,et al.  Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors , 2009, British journal of pharmacology.

[22]  G. Burnstock,et al.  Purinergic regulation of vascular tone and remodelling. , 2009, Autonomic & autacoid pharmacology.

[23]  P. Vanhoutte,et al.  Endothelial dysfunction: the first step toward coronary arteriosclerosis. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[24]  David D. Gutterman,et al.  Vascular control in humans: focus on the coronary microcirculation , 2009, Basic Research in Cardiology.

[25]  R. Webb,et al.  Uridine adenosine tetraphosphate induces contraction and relaxation in rat aorta. , 2008, Vascular pharmacology.

[26]  J. Jankowski,et al.  Up4A stimulates endothelium-independent contraction of isolated rat pulmonary artery. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[27]  A. Patzak,et al.  Uridine adenosine tetraphosphate acts as an autocrine hormone affecting glomerular filtration rate , 2008, Journal of Molecular Medicine.

[28]  Maylis Tartas,et al.  Endothelium‐derived hyperpolarizing factor as an in vivo back‐up mechanism in the cutaneous microcirculation in old mice , 2007, The Journal of physiology.

[29]  J. Peart,et al.  P2 Purinoceptor-Mediated Cardioprotection in Ischemic-Reperfused Mouse Heart , 2007, Journal of Pharmacology and Experimental Therapeutics.

[30]  D. Donnelly-roberts,et al.  P2X7-related modulation of pathological nociception in rats , 2007, Neuroscience.

[31]  S. Soelaiman,et al.  Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists , 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.

[32]  Jiliang Wu,et al.  Endothelial Nitric Oxide Synthase–Dependent Tyrosine Nitration of Prostacyclin Synthase in Diabetes In Vivo , 2006, Diabetes.

[33]  C. Gachet,et al.  The P2Y(1) receptor as a target for new antithrombotic drugs: a review of the P2Y(1) antagonist MRS-2179. , 2006, Cardiovascular drug reviews.

[34]  H. Schlüter,et al.  Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor , 2005, Nature Medicine.

[35]  D. Duncker,et al.  Alterations in Myofilament Function Contribute to Left Ventricular Dysfunction in Pigs Early After Myocardial Infarction , 2004, Circulation research.

[36]  K. Jacobson,et al.  Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. , 2004, Biochemical pharmacology.

[37]  I. Fleming,et al.  Bradykinin‐induced relaxation of coronary microarteries: S‐nitrosothiols as EDHF? , 2004, British journal of pharmacology.

[38]  M. Zou,et al.  Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. , 2004, Endothelium : journal of endothelial cell research.

[39]  C. Garland,et al.  Extracellular ATP facilitates flow-induced vasodilatation in rat small mesenteric arteries. , 2004, American journal of physiology. Heart and circulatory physiology.

[40]  J. Beckman,et al.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I , 2013, European heart journal.

[41]  I. Salmon,et al.  Bosentan for the Prevention of Overcirculation-Induced Experimental Pulmonary Arterial Hypertension , 2003, Circulation.

[42]  J. Zhang,et al.  Age-related changes in P2 receptor mRNA of rat cerebral arteries , 2001, Experimental Gerontology.

[43]  R. Busse,et al.  Cytochrome P450 2C is an EDHF synthase in coronary arteries , 1999, Nature.

[44]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[45]  G. Burnstock,et al.  Effects of streptozotocin-diabetes on sympathetic nerve, endothelial and smooth muscle function in the rat mesenteric arterial bed. , 1995, European journal of pharmacology.

[46]  A. Nitenberg,et al.  Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function , 1993, Diabetes.

[47]  D. Duncker,et al.  Uridine adenosine tetraphosphate is a novel vasodilator in the coronary microcirculation which acts through purinergic P1 but not P2 receptors. , 2013, Pharmacological research.

[48]  W. J. van der Giessen,et al.  Coronary microvascular dysfunction in a porcine model of early atherosclerosis and diabetes. , 2012, American journal of physiology. Heart and circulatory physiology.

[49]  R. Webb,et al.  Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats. , 2012, Pharmacological research.

[50]  Jeroen J. Bax,et al.  Multimodality imaging in diabetic heart disease. , 2011, Current problems in cardiology.

[51]  Geoffrey Burnstock,et al.  Purinergic signalling , 2012, Acta physiologica.